Anti-Phospholipase A2 Receptor in Nonlupus Patients with Membranous Nephropathy and Crescents

Yiqin Zuo1,2, Livia Barreira Cavalcante3, James Monroe Smelser4

  • 1Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Glomerular Diseases
|February 8, 2023
PubMed
Abstract

Insights

In nonlupus patients with membranous nephropathy and crescents, anti-phospholipase A2 receptor (PLA2R) positivity was observed in 31%, suggesting secondary causes. Further research into cryptic epitopes may reveal injury mechanisms.

Area of Science:

  • Nephrology
  • Immunopathology
  • Glomerular Diseases

Background:

  • Primary membranous nephropathy (MN) often involves anti-phospholipase A2 receptor (PLA2R) antibodies.
  • Crescents in nonlupus MN suggest a secondary injury, potentially involving autoantibodies like anti-neutrophil cytoplasmic antibody (ANCA) or anti-glomerular basement membrane (anti-GBM).

Purpose of the Study:

  • To investigate PLA2R staining in nonlupus patients presenting with both MN and glomerular crescents.
  • To explore the association between PLA2R status and concurrent or sequential glomerular injuries.

Main Methods:

  • Analysis of native renal biopsies from 16 nonlupus patients with MN and crescents.
  • Immunohistochemical staining for PLA2R on renal biopsies.

Main Results:

  • The study included 16 nonlupus patients (11 male, 5 female; mean age 61) with MN and crescents.
  • Elevated serum creatinine and proteinuria were common. Two patients had positive anti-GBM antibodies, and 9 of 11 tested were ANCA-positive.
  • PLA2R staining was positive in 5 cases (31%), with 3 of these being ANCA-positive. None of the anti-GBM positive patients were PLA2R positive.

Conclusions:

  • A significant proportion (64%) of patients presented with concurrent MN and crescents.
  • PLA2R positivity in 31% of these cases suggests a higher likelihood of secondary MN.
  • Identifying the triggering mechanisms and cryptic epitopes is crucial for understanding these complex glomerular injuries.

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
17
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
14
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.6K
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.6K